Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 27% ± 12% | |
macrophage | 6 studies | 24% ± 6% | |
oligodendrocyte precursor cell | 6 studies | 27% ± 10% | |
astrocyte | 6 studies | 34% ± 14% | |
oligodendrocyte | 6 studies | 26% ± 10% | |
microglial cell | 5 studies | 24% ± 6% | |
glutamatergic neuron | 5 studies | 42% ± 21% | |
interneuron | 3 studies | 40% ± 20% | |
GABAergic neuron | 3 studies | 45% ± 6% | |
endothelial cell of lymphatic vessel | 3 studies | 17% ± 0% | |
adipocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 34% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1070.56 | 1445 / 1445 | 100% | 7.24 | 183 / 183 |
brain | 100% | 1065.71 | 2637 / 2642 | 99% | 5.86 | 701 / 705 |
breast | 100% | 1144.97 | 459 / 459 | 99% | 6.81 | 1109 / 1118 |
stomach | 100% | 1016.62 | 359 / 359 | 99% | 4.47 | 283 / 286 |
intestine | 100% | 1168.95 | 966 / 966 | 99% | 3.56 | 521 / 527 |
ovary | 100% | 1665.77 | 180 / 180 | 99% | 4.07 | 424 / 430 |
lung | 100% | 1015.03 | 577 / 578 | 99% | 4.64 | 1140 / 1155 |
thymus | 100% | 1316.67 | 653 / 653 | 98% | 4.70 | 595 / 605 |
skin | 100% | 1275.58 | 1809 / 1809 | 98% | 4.74 | 464 / 472 |
uterus | 100% | 1559.44 | 170 / 170 | 98% | 4.55 | 448 / 459 |
prostate | 100% | 1287.55 | 245 / 245 | 97% | 4.43 | 489 / 502 |
kidney | 100% | 861.91 | 89 / 89 | 97% | 4.08 | 871 / 901 |
bladder | 100% | 1166.90 | 21 / 21 | 97% | 3.76 | 487 / 504 |
pancreas | 99% | 660.85 | 326 / 328 | 97% | 3.58 | 172 / 178 |
adrenal gland | 100% | 1015.17 | 258 / 258 | 90% | 2.63 | 206 / 230 |
liver | 100% | 508.45 | 226 / 226 | 76% | 2.00 | 309 / 406 |
adipose | 100% | 1107.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1054.99 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.41 | 1 / 1 |
blood vessel | 100% | 944.97 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 598.04 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 630.89 | 839 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 3.67 | 75 / 80 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.57 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.29 | 26 / 29 |
peripheral blood | 57% | 508.33 | 532 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF236 |
Protein name | Zinc finger protein 236 |
Synonyms | |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | Q9UL36 A0A994J512 ENST00000645888.1 J9JID5 ENST00000253159.12 [Q9UL36-1] ENST00000320610.14 A0A2R8YCW3 ENST00000706008.1 ENST00000543926.6 [Q9UL36-2] |